Results 1 to 10 of about 41,665 (48)
The Event Horizon Telescope Image of the Quasar NRAO 530 [PDF]
Astrophysical Journal, 2023 We report on the observations of the quasar NRAO 530 with the Event Horizon Telescope (EHT) on 2017 April 5−7, when NRAO 530 was used as a calibrator for the EHT observations of Sagittarius A*.
S. Jorstad +269 more
semanticscholar +1 more source
Gastroenterology, 2016 BACKGROUND & AIMS The combination of ABT-493 (NS3/4A protease inhibitor) plus ABT-530 (NS5A inhibitor) has shown high rates of sustained virologic response at post-treatment week 12 (SVR12) in noncirrhotic patients infected with hepatitis C virus (HCV ...
E. Gane +14 more
semanticscholar +1 more source
Scientific Reports, 2017 Aggregatibacter actinomycetemcomitans leukotoxin (LtxA) is a major virulence factor that kills leukocytes permitting it’s escape from host immune surveillance. A. actinomycetemcomitans strains can produce high or low levels of toxin.
V. Sampathkumar +3 more
semanticscholar +1 more source
, 2018 Two new epipolythiodioxopiperazines, named chetracins E and F (1 and 2), along with the known chetracin C (3), were isolated from the fungus Acrostalagmus luteoalbus HDN13-530. Their structures were elucidated based on the NMR, MS and CD data, as well as
Guihong Yu +9 more
semanticscholar +1 more source
Nature Network Boston, 2022 The sodium–glucose cotransporter 2 inhibitor empagliflozin reduces the risk of cardiovascular death or heart failure hospitalization in patients with chronic heart failure, but whether empagliflozin also improves clinical outcomes when initiated in ...
A. Voors +29 more
semanticscholar +1 more source
Antimicrobial Agents and Chemotherapy, 2015 ABT-493 is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor, and ABT-530 is an HCV NS5A inhibitor. These direct-acting antivirals (DAAs) demonstrated potent antiviral activity against major HCV genotypes and high barriers to ...
E. Lawitz +12 more
semanticscholar +1 more source
Liver international (Print), 2016 ABT‐530 is a next‐generation hepatitis C virus (HCV) NS5A inhibitor with potent pangenotypic antiviral activity in vitro. Paritaprevir is an NS3/4A protease inhibitor codosed with ritonavir that displays in vitro activity against HCV genotypes 1–4 and 6.
F. Poordad +8 more
semanticscholar +1 more source
Patient Safety in Surgery, 2014 BackgroundPostoperative complications contribute to morbidity and mortality. This study assessed the impact of surgical complications on healthcare resource utilization for patients undergoing elective colorectal procedures.MethodData were obtained on ...
E. Zoucas, M. Lydrup
semanticscholar +1 more source
Committee opinion no. 530: access to postpartum sterilization.
Obstetrics and Gynecology, 2012 Postpartum tubal sterilization is one of the safest and most effective methods of contraception. Women who desire this type of sterilization typically undergo thorough counseling and informed consent during prenatal care and reiterate their desire for ...
semanticscholar +1 more source
Periodic radio variabilities in NRAO 530: a jet-disc connection?
, 2013 Time series analysis techniques, Lomb-Scargle periodogram and weighted wavelet Z-transform, have been employed to search for year-time-scale periodicities from the radio light curves of a typical blazar NRAO 530.
T. An +4 more
semanticscholar +1 more source